Inventor · disambiguated record
Chunping Lu
Also filed as: LU CHUNPING
6 granted patents·1 pending application·2 citations·filing 2018–2023
67Inventor score
Files withZHEJIANG PALO ALTO PHARMACEUTICALS INC7
Top patents by PatentIndex Score
7 records- 0181US10668090B2Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2018·Granted Jun 2, 2020·2 cites·4 claims
- 0261US2024052350A1Oligonucleotide and use thereof against hepatitis b virus and hepatitis d virusZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0358US10913765B2Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate compound, and application thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2020·Granted Feb 9, 2021·0 cites·3 claims
- 0458US10899787B2Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific delivery and useZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2020·Granted Jan 26, 2021·0 cites·4 claims
- 0557US10913766B2Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and application thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2020·Granted Feb 9, 2021·0 cites·5 claims
- 0647US11008361B2Liver-specific delivery-based anti-hepatitis C prodrug nucleoside cyclo-phosphate compound and uses thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2019·Granted May 18, 2021·0 cites·9 claims
- 0740US10640515B2Hepatitis C virus inhibitor and uses thereofZHEJIANG PALO ALTO PHARMACEUTICALS INC·Filed 2018·Granted May 5, 2020·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →